![PRD_000766 PRD_000766](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000766.svg) | PRD_000766 | Name: | CYCLOSPORIN A, 6 mutation | Formula: | C63 H113 N11 O13 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000767 PRD_000767](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000767.svg) | PRD_000767 | Name: | CYCLOSPORIN A, 7 mutation | Formula: | C63 H113 N11 O13 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_002527 PRD_002527](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002527.svg) | PRD_002527 | Name: | Intermediate for maxamycins synthesis | Formula: | C84 H114 Cl2 N8 O17 S Si2 | Definition date: | 2023-07-05 | Last modified: | 2023-07-05 |
|
![PRD_002431 PRD_002431](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002431.svg) | PRD_002431 | Name: | Cyclic tetraadenosine monophosphate (cA4) | Formula: | C40 H48 N20 O24 P4 | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | Definition date: | 2023-07-12 | Last modified: | 2023-07-03 |
|
![PRD_001065 PRD_001065](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001065.svg) | PRD_001065 | Name: | teicoplanin | Formula: | C88 H97 Cl2 N9 O34 | Definition date: | 2013-05-29 | Last modified: | 2023-06-11 |
|
![PRD_002346 PRD_002346](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002346.svg) | PRD_002346 | Name: | Inhibitor ARC-3126 | Formula: | C58 H108 Br N31 O9 S | Definition date: | 2021-08-04 | Last modified: | 2023-06-11 |
|
![PRD_002353 PRD_002353](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002353.svg) | PRD_002353 | Name: | Blood group B type 1 antigen, beta anomer | Formula: | C26 H45 N O20 | Definition date: | 2022-03-02 | Last modified: | 2023-06-11 |
|
![PRD_002516 PRD_002516](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002516.svg) | PRD_002516 | Name: | cyclic peptide inhibitor 1 | Formula: | C111 H132 N23 O30 S | Definition date: | 2023-03-22 | Last modified: | 2023-03-22 |
|
![PRD_002424 PRD_002424](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002424.svg) | PRD_002424 | Name: | Darobactin 22 | Formula: | C53 H67 N15 O11 | Definition date: | 2023-01-11 | Last modified: | 2023-01-11 |
|
![PRD_002430 PRD_002430](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002430.svg) | PRD_002430 | Name: | Darobactin 9 | Formula: | C49 H57 N12 O12 | Definition date: | 2023-01-11 | Last modified: | 2023-01-11 |
|
![PRD_002492 PRD_002492](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002492.svg) | PRD_002492 | Name: | Sa-D3 | Formula: | C87 H110 N18 O24 S | Definition date: | 2022-08-10 | Last modified: | 2022-08-10 |
|
![PRD_002384 PRD_002384](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002384.svg) | PRD_002384 | Formula: | C58 H95 N15 O15 | Definition date: | 2022-08-03 | Last modified: | 2022-08-03 |
|
![PRD_000468 PRD_000468](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000468.svg) | PRD_000468 | Name: | Allosamidin | Formula: | C25 H42 N4 O14 | Definition date: | 2015-07-18 | Last modified: | 2022-03-03 |
|
![PRD_000041 PRD_000041](https://data.pdbj.org/pdbjplus/data/cc/svg/JS4.svg) | PRD_000041 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-4-(2-(3-AMINOPROPYLAMINO)ETHOXY)-5-((1R,2R,3S,5R,6S)-3,5-DIAM
INO-2-((2S,3R,4R,5S,6R)-3-AMINO-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(
HYDROXYMETHYL)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C28 H57 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
![PRD_000042 PRD_000042](https://data.pdbj.org/pdbjplus/data/cc/svg/JS5.svg) | PRD_000042 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R,4R,5S,6R)-3-AMINO-4
,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(HYDROXYMETHYL)-4-(2-((R)-PIPERIDI
N-3-YLMETHYLAMINO)ETHOXY)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C31 H61 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
![PRD_002479 PRD_002479](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002479.svg) | PRD_002479 | Name: | Cyclic Peptide Inhibitor ZO1-GLN-SER-TPO-45W-MLL | Formula: | C34 H48 F3 N6 O14 P | Definition date: | 2022-03-02 | Last modified: | 2022-03-02 |
|
![PRD_002383 PRD_002383](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002383.svg) | PRD_002383 | Name: | des4.3.1 | Formula: | C44 H74 N12 O11 S | Definition date: | 2021-04-28 | Last modified: | 2021-04-28 |
|
![PRD_002362 PRD_002362](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002362.svg) | PRD_002362 | Name: | GsIN-1 peptide | Formula: | C79 H106 N16 O21 S | Definition date: | 2021-04-21 | Last modified: | 2021-04-21 |
|
![PRD_002267 PRD_002267](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002267.svg) | PRD_002267 | Name: | D-Arg4,Leu10-Teixobactin | Formula: | C59 H101 N14 O14 | Definition date: | 2020-08-19 | Last modified: | 2020-08-19 |
|
![PRD_002272 PRD_002272](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002272.svg) | PRD_002272 | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | Formula: | C25 H44 N14 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_002295 PRD_002295](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002295.svg) | PRD_002295 | Formula: | C89 H131 N23 O25 S3 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
![PRD_900060 PRD_900060](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900060.svg) | PRD_900060 | Name: | ACARBOSE DERIVED HEXASACCHARIDE | Formula: | C36 H63 N O29 | Description: | oligosaccharide with N-glycosidic bond between monosaccharides | Definition date: | 2020-07-29 | Last modified: | 2020-08-05 |
|
![PRD_900106 PRD_900106](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900106.svg) | PRD_900106 | Name: | 6-S-alpha-D-mannopyranosyl-6-thio-alpha-D-mannopyranose | Formula: | C12 H22 O10 S | Description: | oligosaccharide with S-glycosidic bond between monosaccharides | Definition date: | 2020-07-29 | Last modified: | 2020-08-05 |
|
![PRD_900010 PRD_900010](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900010.svg) | PRD_900010 | Name: | MALTOTETRAOSE | Formula: | C24 H42 O21 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900011 PRD_900011](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900011.svg) | PRD_900011 | Name: | beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranose | Formula: | C24 H42 O21 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|